Increase in Cases of Depression Expected to Drive Global Antidepressants Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Antidepressants market comprises of sales of antidepressants & related services that are used in hospitals & clinics and retail pharmacies. Antidepressants are drugs that can aid to alleviate depressive symptoms, anxiety disorders, seasonal affective disorder, social anxiety disorder, and dysthymia, or moderate persistent depressive and other conditions. According to study, “Antidepressants Global Market Report 2020-30: Covid 19 Implications and Growth” the key companies operating in the global antidepressants market are Eli Lilly and Company; GlaxoSmithKline PLC; Allergan PLC; AstraZeneca; H. Lundbeck AS; Merck & Co. Inc.; Sanofi; Johnson & Johnson; Pfizer Inc.; Sun Pharmaceuticals Pvt Ltd; Teva Pharmaceutical Industries; Alkermes; Bristol Myers Squibb Company; Eli Lilly and Co.; Forest laboratories; Akeda Pharmaceutical; Takeda Pharmaceutical Co. Ltd and others. Additionally, the research & development (R&D) activities by the key players have resulted in rising product approvals & have a pipeline of products under development. Based on product type, antidepressants market is segmented as Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Selective Serotonin Reuptake Inhibitor (SSRI), Monoamine Oxidase Inhibitor (MAOI), Tricyclic Antidepressant (TCA) and other products. SSRI segment holds major share in global market owing to presence of large number of these drugs. Based on depressive disorder, market is segmented as Obsessive-compulsive Disorder (OCD), major depressive disorder, Panic Disorder (PD), Generalized Anxiety Disorder (GAD), and others. In addition, based on drug class, market is segmented as serotonin antagonist & reuptake inhibitors, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and tricyclic antidepressants. The antidepressants market is driven by rise in awareness about depression, followed by increase in number of cases of depression around the world and emergence of novel biologics. However, side-effects & patent expiry of antidepressant drugs and preference of non-pharmacological therapies over the pharmacological therapies may impact the market. Moreover, rise in number of patients suffering from stress and increase in awareness regarding the disease states are key opportunities for market. Furthermore, treatment for resistant depression is a major trend for market. Corona-Virus or COVID-19 pandemic is predictable to have a considerable positive impact on the growth of the studied market. The pandemic is anticipated to have a long & short term impact on the people’s mental illness given the hurdles faced during the crisis, for instance social isolation owing to lockdown, job insecurity, and fear of being infected by Covid-19. According to the survey, about 64% of the household had experienced at least one adverse effect in lockdown, such as increase in alcohol consumption or substance use, difficulty sleeping or eating, and worsening chronic conditions, on their mental health & wellbeing during the pandemic. Thus, due to increasing incidence of depression & anxiety among the global population over the Covid-19 pandemic, the antidepressant market is probable to have a significant impact during the Corona-virus crisis. Based on geography, the North-American region dominates the global antidepressants market owing to increase in cases of depression in the region. The Asian-Pacific and European regions are estimated to exhibit higher growth rate due to presence of large pool of geriatric population and increase in marketing approval for new medicines over the forecast period. The global antidepressants market is anticipated to grow from US &14.3 billion in 2019 to approximately US $28.6 billion in 2020 as mental health issues are likely to surge owing to the effects of the Corona-Virus pandemic making an impact on the global economy. The market is projected to stabilize and reach US $19 billion at a CAGR of 7.4% through 2023. For More Information, Click on the Link Below:- Global Antidepressants Market Related Reports:- Global Antidepressants Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024 Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Allergan PLC Antidepressants Market Share, Antidepressants Market, Antidepressants Market Competitive Landscape, Antidepressants Market Forecast, Antidepressants Market Overview, Antidepressants Market Segmentation, Asia-Pacific Antidepressants Market, AstraZeneca Antidepressants Market Share, Australia Antidepressants Market, China Antidepressants Market, Covid-19 Impact Global Antidepressants Industry, Covid-19 Impact Global Antidepressants Market, Eli Lilly and Company Antidepressants Market Revenue, Generalized Anxiety Disorder Market, Germany Antidepressants Market, Global Antidepressants Industry, Global Antidepressants Industry Research Report, Global Antidepressants Market, Global Antidepressants Market Analysis, Global Antidepressants Market Growth, Global Antidepressants Market Major Players, Global Antidepressants Market Research Report, Global Antidepressants Market Share, Global Antidepressants Market Size, Global Antidepressants Market Trends, India Antidepressants Market, Japan Antidepressants Market, Major Depressive Disorder Market, Obsessive-Compulsive Disorder Market, Panic Disorder Market, Teva Pharmaceutical Industries Antidepressants Market Share